Phase I First in Human Study

The purpose of this trial is to determine the safety, tolerability and feasibility of the immunotherapy with MVX-ONCO-1, in patients with advanced metastatic solid tumors in progression who are not or not any longer amenable to any standard therapy of their tumour diseases.

Status: Enrolment completed